SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-086214
Filing Date
2024-10-08
Accepted
2024-10-08 14:12:49
Documents
26
Period of Report
2024-10-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0216936-8k_oramed.htm   iXBRL 8-K 90346
2 SECURITIES PURCHASE AGREEMENT, DATED OCTOBER 7, 2024, BY AND BETWEEN SCILEX HOLD ea021693601ex10-1_oramed.htm EX-10.1 406832
3 AMENDMENT NO. 1 TO SCILEX-ORAMED SPA, DATED OCTOBER 8, 2024, BY AND BETWEEN SCIL ea021693601ex10-2_oramed.htm EX-10.2 20112
4 TRANCHE B SENIOR SECURED CONVERTIBLE NOTE, DATED OCTOBER 8, 2024, ISSUED BY SCIL ea021693601ex10-3_oramed.htm EX-10.3 423813
5 WARRANT TO PURCHASE COMMON STOCK, DATED OCTOBER 8, 2024, ISSUED BY SCILEX HOLDIN ea021693601ex10-4_oramed.htm EX-10.4 174873
6 PURCHASE AND SALE AGREEMENT, DATED OCTOBER 8, 2024, BY AND AMONG SCILEX HOLDING ea021693601ex10-5_oramed.htm EX-10.5 395985
7 SECURITY AGREEMENT, DATED OCTOBER 8, 2024, BY AND AMONG SCILEX PHARMACEUTICALS I ea021693601ex10-6_oramed.htm EX-10.6 96197
8 SUBORDINATION AGREEMENT, DATED OCTOBER 8, 2024, BY AND AMONG SCILEX PHARMACEUTIC ea021693601ex10-7_oramed.htm EX-10.7 115609
9 CONSENT AND AMENDMENT, DATED AS OF OCTOBER 8, 2024, BY AND BETWEEN SCILEX HOLDIN ea021693601ex10-8_oramed.htm EX-10.8 63367
10 SUBSIDIARY GUARANTEE AMENDMENT, DATED OCTOBER 8, 2024, MADE BY CERTAIN OF SCILEX ea021693601ex10-9_oramed.htm EX-10.9 29088
11 AMENDED AND RESTATED SECURITY AGREEMENT, DATED OCTOBER 8, 2024, BY AND AMONG SCI ea021693601ex10-10_oramed.htm EX-10.10 201367
12 REST OF WORLD LICENSE TERM SHEET, DATED OCTOBER 8, 2024, BETWEEN ORAMED PHARMACE ea021693601ex10-11_oramed.htm EX-10.11 68976
13 AGREEMENT AMONG HOLDERS, DATED OCTOBER 8, 2024, BY AND BETWEEN ORAMED PHARMACEUT ea021693601ex10-12_oramed.htm EX-10.12 209463
14 PRESS RELEASE DATED OCTOBER 7, 2024 ea021693601ex99-1_oramed.htm EX-99.1 12137
  Complete submission text file 0001213900-24-086214.txt   2979856

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE ormp-20241007.xsd EX-101.SCH 3009
16 XBRL LABEL FILE ormp-20241007_lab.xml EX-101.LAB 34240
17 XBRL PRESENTATION FILE ormp-20241007_pre.xml EX-101.PRE 22355
28 EXTRACTED XBRL INSTANCE DOCUMENT ea0216936-8k_oramed_htm.xml XML 3688
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 241359954
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)